Biovica International AB Stock price
Equities
BIOVIC B
SE0008613731
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 SEK | -0.61% | -2.77% | -4.65% |
Sales 2024 * | 10M 935K | Sales 2025 * | 116M 10.85M | Capitalization | 208M 19.46M |
---|---|---|---|---|---|
Net income 2024 * | -110M -10.29M | Net income 2025 * | -51M -4.77M | EV / Sales 2024 * | 12.1 x |
Net cash position 2024 * | 86.7M 8.11M | Net cash position 2025 * | 43.01M 4.02M | EV / Sales 2025 * | 1.42 x |
P/E ratio 2024 * |
-0.19
x | P/E ratio 2025 * |
-0.83
x | Employees | 37 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.54% |
Latest transcript on Biovica International AB
1 day | +0.20% | ||
1 week | -1.98% | ||
Current month | +16.98% | ||
1 month | +12.47% | ||
3 months | -7.98% | ||
6 months | -65.79% | ||
Current year | -3.88% |
Managers | Title | Age | Since |
---|---|---|---|
Anders Rylander
CEO | Chief Executive Officer | 54 | 09-12-31 |
Anders Morén
DFI | Director of Finance/CFO | 59 | 22-12-31 |
Hanna Ritzen
CTO | Chief Tech/Sci/R&D Officer | 45 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 64 | 19-03-19 | |
Annika Berg
BRD | Director/Board Member | 61 | 19-12-31 |
Maria Holmlund
BRD | Director/Board Member | 68 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.46 | -0.61% | 12 874 |
24-03-27 | 2.475 | -1.98% | 220,706 |
24-03-26 | 2.525 | -0.20% | 50,618 |
24-03-25 | 2.53 | -0.20% | 87,266 |
24-03-22 | 2.535 | +0.20% | 223,699 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 05:14 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.88% | 19.59M | |
-9.60% | 12.14B | |
+73.43% | 3.94B | |
-33.60% | 2.19B | |
-21.05% | 1.63B | |
+30.99% | 1.14B | |
+9.17% | 852M | |
-12.33% | 545M | |
-41.02% | 419M | |
+28.48% | 249M |